The Online Investor
Diagnostics M&A image Diagnostics M&A » By The Online Investor Staff, updated Sat., Sep. 19, 10:42 AM Recent mergers and acquisitions in the Diagnostics M&A category.

Slide #58. Quintiles Novella Clinical

Acquirer: Quintiles (Q)
Acquiree: Novella Clinical
Details: To stay ahead of the diverse and evolving needs of its global customer base, Quintiles today announced it has signed an agreement to acquire Novella Clinical (Novella), a full-service clinical research organization (CRO) focused primarily on emerging oncology customers as well as those in the medical device and diagnostics sectors.

Quintiles IMS Holdings is an integrated information and technology-enabled healthcare service provider. Co. has three operating segments: Commercial Solutions, Research & Development Solutions and Integrated Engagement Services. Co.'s principal Commercial Solutions offerings include: national information offerings and sub-national information offerings. Co.'s principal Research & Development Solutions offerings include: project management and clinical monitoring, clinical trial support services, and Q2 Solutions. Co.'s principal Integrated Engagement Services offerings include: health care provider engagement services, patient engagement services, and medical affairs services.

Open the Q Page at The Online Investor »

Company Name: 
IQVIA Holdings Inc
Stock buyback: 
Q buyback
Website: 
www.quintiles.com
Sector: 
Biotechnology
 

Open the Q Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Buy (2.85 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Diagnostics M&A - Slide 58 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.